New Results
Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae
Christopher A. Rice, View ORCID ProfileBeatrice L. Colon, Emily Chen, View ORCID ProfileMitchell V. Hull, View ORCID ProfileDennis E. Kyle
doi: https://doi.org/10.1101/2020.05.13.093922
Christopher A. Rice
1Department of Cellular Biology, University of Georgia, Athens, Georgia, USA
2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA, 30602
Beatrice L. Colon
2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA, 30602
3Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA
Emily Chen
4Calibr at Scripps Research, La Jolla, CA, USA, 92037
Mitchell V. Hull
4Calibr at Scripps Research, La Jolla, CA, USA, 92037
Dennis E. Kyle
1Department of Cellular Biology, University of Georgia, Athens, Georgia, USA
2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA, 30602
3Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA
Article usage
Posted May 13, 2020.
Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae
Christopher A. Rice, Beatrice L. Colon, Emily Chen, Mitchell V. Hull, Dennis E. Kyle
bioRxiv 2020.05.13.093922; doi: https://doi.org/10.1101/2020.05.13.093922
Subject Area
Subject Areas
- Biochemistry (12806)
- Bioengineering (9690)
- Bioinformatics (31296)
- Biophysics (16118)
- Cancer Biology (13197)
- Cell Biology (18873)
- Clinical Trials (138)
- Developmental Biology (10217)
- Ecology (15201)
- Epidemiology (2067)
- Evolutionary Biology (19418)
- Genetics (12890)
- Genomics (17789)
- Immunology (12921)
- Microbiology (30225)
- Molecular Biology (12617)
- Neuroscience (65963)
- Paleontology (487)
- Pathology (2042)
- Pharmacology and Toxicology (3519)
- Physiology (5455)
- Plant Biology (11310)
- Synthetic Biology (3124)
- Systems Biology (7771)
- Zoology (1758)